Brimonidine Tartrate Solution/ Drops
Product Images NDC 60505-0564

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate (NDC 60505-0564). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle-0-15pct-10ml (Bottle 0 15pct 10ml)

Label for Brimonidine Tartrate Ophthalmic Solution 0.15%, a 10 mL eye drop solution by Apotex Corp. The label indicates topical ophthalmic use, Rx only, sterile, and includes storage instructions and typical dosage information.*

FDA Label Image

Structural Formula (Brimonidine Tartrate)

Chemical structure of brimonidine tartrate, showing the molecular arrangement of the active ingredient in the product Brimonidine Tartrate 1.5 mg/mL ophthalmic solution by Apotex Corp.*

FDA Label Image

Carton-0-15pct-10ml (Carton 0 15pct 10ml)

Label for Brimonidine Tartrate 0.15% ophthalmic solution by Apotex Corp. The 10 mL bottle is for topical ophthalmic use only. The label includes active and inactive ingredients, storage instructions, dosage directions to apply one drop three times daily, tamper-evident warning, and manufacturer addresses in Ontario, Canada and Weston, Florida. The packaging features NDC 60505-0564-2 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.